home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next

Endpoint Protection in Rare Disease Trials: Safeguarding Data Integrity for Reliable Outcomes

  January 24, 2024  
Xtalks, Online

This webinar will explore strategies to build a comprehensive approach to endpoint protection in rare disease clinical trials, thereby ensuring the integrity and reliability of study outcomes. The integrity of clinical trials depends on accurate and reliable data, making the protection of endpoints a critical aspect of the entire process. Endpoints, which are specific outcomes used to measure the effectiveness of an intervention, must be safeguarded to ensure the validity and credibility of the trial results. Endpoint protection is particularly important in rare disease trials as these studies often involve small patient populations and face distinct methodological challenges. Every data point is essential to the success of the study.

Join this webinar to gain insights into essential strategies for constructing a robust framework for endpoint protection in rare disease clinical trials.

Keywords: Clinical Trials, Clinical Research, CRO, Clinical Trial Data, Clinical Data, Rare Disease Clinical Trials, Clinical Trial Endpoints, Rare Diseases/Orphan Drugs
Organized by: Xtalks
Invited Speakers: Angi Robinson, Senior Vice President, Specialty Areas, Premier Research
Deadline for Abstracts: 2024-02-22
Registration: Free Registration
E-mail: tristan@xtalks.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.